Literature DB >> 20306454

Neuroleptic malignant syndrome and its controversies.

Branimir Margetić1, Branka Aukst-Margetić.   

Abstract

PURPOSE: Neuroleptic malignant syndrome (NMS) is a rare and life threatening condition usually defined as a complication of treatment with antipsychotics characterized by severe rigidity, tremor, fever, altered mental status, autonomic dysfunction, and elevated serum creatine phosphokinase and white blood cell count. The literature on this topic is rather extensive, but many aspects related to the syndrome are thought to be controversial. The aim of this paper, written with the clinician in mind, is to summarize some of the most prominent controversies that may have importance in usual clinical practice.
METHODS: The literature was searched for reviews, reports on the series of cases, individual case reports of NMS, and other clinically and theoretically important information.
RESULTS: There are controversies associated with virtually all important aspects of NMS. At the moment, it is not clear if this drug reaction is idiosyncratic or not, what diagnostic criteria are the most appropriate for usual clinical practice, and it seems that the estimated incidence is not in accordance with the number of treated patients. There are rather different approaches to the pathophysiological mechanisms, differential diagnosis, and treatment.
CONCLUSIONS: Some of the controversies related to NMS have an influence on our understanding of the condition and may have importance in clinical practice. There is a need for further research that should elucidate these controversies. (c) 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20306454     DOI: 10.1002/pds.1937

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  11 in total

Review 1.  Serotonin syndrome versus neuroleptic malignant syndrome: a challenging clinical quandary.

Authors:  Rupal Dosi; Annirudh Ambaliya; Harshal Joshi; Rushad Patell
Journal:  BMJ Case Rep       Date:  2014-06-23

2.  Anesthetic management of a pediatric patient with neuroleptic malignant syndrome.

Authors:  Tarun Bhalla; Douglas Maxey; Amod Sawardekar; Joseph D Tobias
Journal:  J Anesth       Date:  2011-11-19       Impact factor: 2.078

3.  [Neuroleptic malignant syndrome : Rare cause of fever of unknown origin].

Authors:  R Chackupurakal; U Wild; M Kamm; F Wappler; D Reske; S G Sakka
Journal:  Anaesthesist       Date:  2015-06-30       Impact factor: 1.041

4.  Dopamine transporter single-photon emission computerized tomography supports diagnosis of akinetic crisis of parkinsonism and of neuroleptic malignant syndrome.

Authors:  G Martino; M Capasso; M Nasuti; L Bonanni; M Onofrj; A Thomas
Journal:  Medicine (Baltimore)       Date:  2015-04       Impact factor: 1.889

Review 5.  Second-generation antipsychotics and neuroleptic malignant syndrome: systematic review and case report analysis.

Authors:  Martino Belvederi Murri; Argentina Guaglianone; Michele Bugliani; Pietro Calcagno; Matteo Respino; Gianluca Serafini; Marco Innamorati; Maurizio Pompili; Mario Amore
Journal:  Drugs R D       Date:  2015-03

6.  Catatonic Symptoms Appearing before Autonomic Symptoms Help Distinguish Neuroleptic Malignant Syndrome from Malignant Catatonia.

Authors:  Takayuki Komatsu; Tomohisa Nomura; Hiroki Takami; So Sakamoto; Keiko Mizuno; Hajime Sekii; Kotaro Hatta; Manabu Sugita
Journal:  Intern Med       Date:  2016-10-01       Impact factor: 1.271

Review 7.  Pyrexia: aetiology in the ICU.

Authors:  Daniel J Niven; Kevin B Laupland
Journal:  Crit Care       Date:  2016-09-01       Impact factor: 9.097

Review 8.  Neuroleptic malignant syndrome: an easily overlooked neurologic emergency.

Authors:  Ramadhan Oruch; Ian F Pryme; Bernt A Engelsen; Anders Lund
Journal:  Neuropsychiatr Dis Treat       Date:  2017-01-16       Impact factor: 2.570

9.  Neuroleptic malignant syndrome: a case responding to electroconvulsive therapy plus bupropion.

Authors:  Quintí Foguet-Boreu; Montse Coll-Negre; Montse Serra-Millàs; Miquel Cavalleria-Verdaguer
Journal:  Clin Pract       Date:  2018-01-26

10.  Ascertaining instances of neuroleptic malignant syndrome in a secondary mental healthcare electronic medical records database: the SLAM BRC Case Register.

Authors:  Chin-Kuo Chang; Simon Harrison; William Lee; David Taylor; Robert Stewart
Journal:  Ther Adv Psychopharmacol       Date:  2012-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.